Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 2

Federal regulations

Agency
  • DOC231
  • DOT212
  • SEC
201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Compliance3
    • Operations2
    • Administration1
    • Finance1
    • Human Resources1
    Recency
    • Last 30 days
    • Last 7 days
    CMSRemove filter: CMSDOJRemove filter: DOJNIHRemove filter: NIHClear all
    • Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
      June 17, 2026

      Wedgewood Pharmacy LLC applied for registration as an importer of controlled substances with the Drug Enforcement Administration.

    • Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
      June 16, 2026

      Proposed rule codifies Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022 and establishes new policies for drug benefit programs and fixed combination drugs.

    • Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
      June 16, 2026

      Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.

    • Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line
      June 16, 2026

      The National Cancer Institute offers licensing of the A1847 human ovarian carcinoma cell line, a BRCA1-deficient model for researchers studying cell cycle regulation, tumor suppression, and DNA damage repair drugs.

    • Center for Scientific Review; Notice of Closed Meetings
      June 16, 2026

      Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.

    • Agency Information Collection Activities; Proposed eCollection eComments Requested; New collection; Requests for DOJ Certification Letters for T Visa Holders
      June 16, 2026

      DOJ's Office of Justice Programs seeks OMB approval for a new information collection on T visa certification letter requests; public comments accepted through the Federal Register notice period.

    • Agency Information Collection Activities: Submission for OMB Review; Comment Request
      June 16, 2026

      CMS is soliciting public comments on proposed information collection activities under the Paperwork Reduction Act; interested parties may submit feedback on burden estimates and collection methodology.

    • Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
      June 16, 2026

      NIH submits its Extramural Harassment Web Form for OMB review under the Paperwork Reduction Act, with a 30-day public comment period.

    • Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
      June 15, 2026

      Veranova, L.P. has applied for DEA registration as a bulk manufacturer of controlled substances; supplementary drug information is available in regulatory notices.

    • Importer of Controlled Substances Application: Cerilliant Corporation
      June 15, 2026

      Cerilliant Corporation seeks DEA registration as an importer of controlled substances; refer to supplementary information for specific drug classes.

    PreviousPage 2 of 13 (122 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants